Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.

Aging
Jin BaiZhi Li

Abstract

Immune checkpoint blockade (ICB) has achieved unprecedented breakthroughs in various cancers, including gastric cancer (GC) with high immune activity (MSI-H or TMB-H), yet clinical benefits from ICB were moderate. Here we aimed to identify the most appropriate drugs which can improve outcomes in GC. We firstly compared MSI-H and TMB-H GC samples with normal samples in TCGA-STAD cohort, respectively. After that, Connectivity Map database repurposed nine candidate drugs (CMap score < -90). Then, microtubule inhibitors (MTIs) were screened as the significant candidate drugs with their representative gene sets strongly enriched (p < 0.05) via GSEA. GDSC database validated higher activities of some MTIs in GC cells with MSI-H and TMB-H (p < 0.05). Furthermore, some MTIs activities were positively associated with mutant Dynein Cytoplasmic 1 Heavy Chain 1 (DYNC1H1) (p < 0.05) based on NCI-60 cancer cell line panel. DYNC1H1 was high frequently alteration in GC and was positively associated with TMB-H and MSI-H. Mutant DYNC1H1 may be accompanied with down-regulation of MTIs-related genes in GC or change the binding pocket to sensitize MTIs. Overall, this study suggested that some MTIs may be the best candidate drugs to treat GC with hig...Continue Reading

References

Feb 22, 1979·Nature·P B SchiffS B Horwitz
Jun 13, 2001·International Journal for Parasitology·P Köhler
Apr 2, 2009·Journal of the Peripheral Nervous System : JPNS·Ilaria RoglioRoberto C Melcangi
Jun 19, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Galina V ShurinMichael R Shurin
Jul 14, 2009·Journal of Translational Medicine·Ramon KanenoMichael R Shurin
Apr 21, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gloria S HuangSusan Band Horwitz
Oct 5, 2010·Nature Reviews. Drug Discovery·Charles Dumontet, Mary Ann Jordan
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 24, 2011·Nature Structural & Molecular Biology·Takahide KonGenji Kurisu
Nov 19, 2011·Radiation Oncology·Kirtesh PatelSeth J Orlow
Mar 30, 2012·Omics : a Journal of Integrative Biology·Guangchuang YuQing-Yu He
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jun 5, 2012·The New England Journal of Medicine·Julie R BrahmerJon M Wigginton
Jan 30, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexandra SevkoViktor Umansky
Sep 12, 2015·Science·Eliezer M Van AllenLevi A Garraway
Oct 6, 2015·Annual Review of Cell and Developmental Biology·Michael A CianfroccoSamara L Reck-Peterson
Dec 26, 2015·Nucleic Acids Research·Antonio ColapricoHoutan Noushmehr
May 20, 2016·Methods in Molecular Biology·Stefan Florian, Timothy J Mitchison
Feb 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Ha Thi HoangSimon L Bullock
Apr 30, 2017·Molecular and Cellular Probes·Ceren Sucularli, Melda Arslantas
Oct 11, 2017·Cell·A Gordon RobertsonSeth P Lerner
Jan 1, 2017·JCO Precision Oncology·Russell BonnevilleSameek Roychowdhury
Aug 25, 2019·Cancer Treatment Reviews·Massimiliano SalatiStefano Cascinu
Feb 27, 2020·Nature Communications·Noritaka NishidaMasahide Kikkawa

❮ Previous
Next ❯

Datasets Mentioned

BETA
GSE90564

Software Mentioned

Cytoscape
R package rcellminer
TCGAbiolinks
R package
clusterprofiler
Search Tool for the Retrieval of Interacting Genes ( STRING
GSEA enrichment analysis
package
STAD
R package TCGAbiolinks

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Related Papers

Cephalalgia : an International Journal of Headache
Trends in Neurosciences
Giampietro SchiavoElizabeth M C Fisher
Cephalalgia : an International Journal of Headache
© 2021 Meta ULC. All rights reserved